CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

Experimental Hematology

Volumn 30, Issue 1, 2002, Pages 26-33

  Bechter, O E ^a   Eisterer, W ^a   Dlaska, M ^a   Kuhr T ^a   Thaler, J ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CLINICAL ARTICLE; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE MUTATION; HUMAN; LYMPHATIC LEUKEMIA; MALE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; TELOMERE;

AGED; AGED, 80 AND OVER; CPG ISLANDS; DNA METHYLATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, B-CELL; MALE; MIDDLE AGED; PROMOTER REGIONS (GENETICS); TELOMERASE;

EID: 0036142690     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00760-3     Document Type: Article

References (50)

1. Structure and function of telomeres
2. Telomere length regulation
3. Origin of concatemeric T7 DNA
4. Telomere end-replication problem and cell aging
5. Telomeres shorten during aging of human fibroblasts
6. The telomere hypothesis of cellular aging
7. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
8. Functional evidence for an RNA template in telomerase
9. A mammalian telomerase associated protein
10. hEST2, the putative human telomerase catalytic subunit gene is up-regulated in tumor cells and during immortalization
11. The RNA component of human telomerase
12. Human telomerase RNA and telomerase activity in immortal cell clones and tumor tissue
13. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types
14. Telomerase catalytic subunit homologs from fission to yeast and human
15. Extension of life span by introduction of telomerase into normal human cells
16. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
17. Telomerase activity is restored in human cells by ecotopic expression of hTERT, the catalytic subunit of telomerase
18. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT)
19. Cloning and characterization of the promoter region of human telomerase reverse transcriptase
20. Target mutation of DNA methyltransferase gene results in embryonic lethality
21. RNA and the epigenetic regulation of X chromosome inactivation
22. Role of DNA methylation in genomic imprinting
23. Transcription of IAP endogenous retroviruses in constrained by cytosine methylation
24. Cancer epigenetics comes of age
25. DNA methylation; past, present and future directions
26. Hypomethylation of DNA from benign and malignant human colon neoplasms
27. 5-Methylcytosine as an endogenous mutagen in human LDL receptor and p53 gene
28. Telomere length and telomerase activity predict survival in patients with B-cell chronic lymphocytic leukemia
29. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands
30. Methylation-specific PCR; a novel PCR assay for methylation status of CpG islands
31. National Cancer Institute-sponsored working group guidelines for chronic lymphocytic leukemia
32. Diagnostic and prognostic value of immunohistological bone marrow examination; results in 212 patients with lymphoproliferative disorders
33. Clinical staging of chronic lymphocytic leukemia
34. Chronic lymphocytic leukemia; proposal for a revised prognostic staging system
35. Specific association of human telomerase activity with immortal cells and cancer
36. Methylation of the human telomerase gene CpG island
37. Nonparametric estimation for incomplete observations
38. Analysis of cytokine mRNA and DNA; detection and quantitation by competitive polymerase chain reaction
39. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
40. Quantitation of follicular non-Hodgkin's lymphoma cells carrying t(14;18) by competitive polymerase chain reaction
41. Detection and quantitation of genetically marked acute myeloid leukemia by competitive polymerase chain reaction after autologous bone marrow transplantation; a preclinical model for minimal residual disease
42. Mathematical considerations of competitive polymerase chain reaction
43. DNA methylation analysis of the promoter region of the human telomerase reverse transcriptase (hTERT) gene
44. High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines
45. The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene
46. Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1
47. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT)
48. Demethylating reagent 5-azacytidine inhibits telomerase activity in human prostate cancer cells through transcriptional repression of hTERT
49. The CpG dinucleotide and human genetic disease
50. Effects of DNA methylation on DNA-binding proteins and gene expression